CHPA Quantifies OTCs’ Overall Value To Promote Expanded Access

 
• By Carolyn B. Phenicie

Information from the CHPA-commissioned study could help improve policymakers’ understanding of the costs of making OTCs less available as well as the benefits of more Rx-to-OTC switches.

The Consumer Healthcare Products Association hopes $102 billion in annual health care savings will draw attention to its arguments for expanding access to OTC drugs.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America